Journal Article

Two ATM variants and breast cancer risk

Spurdle, Amanda, Giles, Graham G., Wayne, Tierney, Milne, Roger, Investigators, kConFab, Chen, Xiaoqing, Hopper, John L., Thompson, Deborah, Sambrook, Joseph, Thorstenson, Yvonne, Oefner, Peter, Tesoriero, Andrea, Khanna, Kum Kum, Antoniou, Antonis C., Marsh, Anna, Chenevix-Trench, Georgia, Southey, Melissa, Goldgar, David, Jenkins, Mark, Easton, Doug

2005

Overview

The ATM gene is mutated in ataxia‐telangiectasia (AT). Heterozygote female relatives of AT cases have a 2‐7fold increased risk of breast cancer. We previously reported high risks of breast cancer associated with certain ATM variants. To estimate the risks more precisely, we have examined two ATM variants, c.1066‐6T>G (IVS10‐6T>G) and c.4258C>T (p.Leu1420Phe), in additional cases and controls from the same Australian cohorts previously used to estimate the risk of breast cancer associated with c.1066‐6T>G. A total of 775 and 84 population‐based controls were genotyped for the c.1066‐6T>G and c.4258C>T ATM variants respectively, as were index cases from 378 and 373 non‐BRCA1/2 breast cancer families. Penetrance was estimated by Bayes factor analysis. The allele frequencies of ATM c.1066‐6T>G and c.4258C>T estimated from controls were 0.005 (95% CI=0.002 to 0.009) and 0.012 (95% CI=0.001 to 0.042), respectively. We identified three new breast cancer families with c.1066‐6T>G, and seven families with c.4258C>T. Combining with the two c.1066‐6T>G families previously reported, the estimated penetrance to age 70 of c.1066‐6T>G was 17.2% (95% CI=4.7% to 37.5%). For c.4258C>T, the estimated average penetrance was 4.8% (95% CI 1.7% to 10.1%). In conclusion, we found no evidence that the ATM c.4258C>T variant increases breast cancer risk, and little evidence that c.1066‐6T>G confers an elevated risk. Analysis of additional families will be necessary to define more precisely the risk, if any, associated with c.1066‐6T>G. © 2005 Wiley‐Liss, Inc.

• Publisher: Wiley Subscription Services, Inc., A Wiley Company,John Wiley & Sons, Inc
• Subject: ataxia telangiectasia mutated / Ataxia Telangiectasia Mutated Proteins / ATM / Bayes Theorem / Breast cancer / Breast Neoplasms - genetics / Cell Cycle Proteins - genetics / DNA-Binding Proteins - genetics / Exons - genetics / Female / Genetic Predisposition to Disease - genetics / Homozygote / Humans / Mutation - genetics / Protein-Serine-Threonine Kinases - genetics / risk / Tumor Suppressor Proteins - genetics / variant